Business Context and Reporting Period
This Form 6-K filing by AMBEV S.A. covers the month of December 2023, specifically dated December 28, 2023. The report discloses recurring related-party transactions required under Annex F of CVM Resolution No. 80/2022. The transactions involve the production, import, and distribution of Corona brand products by Ambev subsidiaries (Labatt Brewing Company Ltd., Cervecería y Maltería Quilmes S.A.I.C.A. y G., and Cervecería Chile S.A.) in Canada, Argentina, and Chile.
Key Financial Metrics
The filing text does not provide specific numerical values for revenue, profit, cash flow, margins, debt, or liquidity. The document focuses on the qualitative terms of the related-party agreements rather than quantitative financial performance for the period.
Material Changes and Transaction Terms
- Counterparty: The transactions are with Cervecería Modelo, S. de R.L. de C.V., a company controlled by Anheuser-Busch InBev SA/NV (AB InBev), which is also the indirect controlling shareholder of Ambev.
- Consideration: Ambev's subsidiaries will pay royalties to Cervecería Modelo for the production, import, and distribution of Corona Products, in addition to an initial amount for exploitation rights.
- Strategic Rationale: The transactions support the expansion of the premium beer segment, leveraging the high consumer preference for Corona Products in the specified territories to generate strategic, operational, and financial advantages.
Management Commentary, Risks, and Governance
Management asserts that the transactions comply with commutative conditions and arm's length principles, validated by an economic study prepared by an independent consultancy company. The filing explicitly states that neither Cervecería Modelo nor its shareholders or managers participated in the decision-making process or negotiations. The transactions were analyzed and recommended by the Governance Committee and approved by the Board of Directors, with no board members related to Cervecería Modelo or AB InBev participating in the discussions or resolutions.
Investor Verification Checklist
- Verify the specific royalty rates and the initial amount for exploitation rights in the full licensing agreements, as these figures are not disclosed in this summary.
- Confirm the total volume of Corona Products produced and distributed in Canada, Argentina, and Chile to assess the materiality of the related-party revenue impact.
- Review the independent economic study referenced to validate the arm's length nature of the pricing terms.
- Monitor future filings for any changes in the scope of the brand licensing or the territories covered.